Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05200455 · ClinicalTrials.gov registry record · NA
Microelectrodes in Epilepsy
A NA study, sponsored by Dartmouth-Hitchcock Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 34
- Enrollment target
NCT05200455 is a NA study that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 34 participants.
The verdict
NCT05200455, a NA study, has completed, sponsored by Dartmouth-Hitchcock Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 34 participants
- Enrollment target
Study Summary
The purpose of this study is to test microelectrodes in intracranial monitoring to see if they will provide novel information on the epileptic potential of the implanted brain tissue. A secondary objective is to investigate the activity of single neurons during specific cognitive tasks.
Interventions
- DEVICE Microelectrodes
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2009-09-18 |
| Est. Completion | 2021-05-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05200455
The ClinicalTrials.gov registry entry for NCT05200455 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Microelectrodes is the first listed.
NCT05200455 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05200455 about?
NCT05200455 is a clinical study titled "Microelectrodes in Epilepsy". The purpose of this study is to test microelectrodes in intracranial monitoring to see if they will provide novel information on the epileptic potential of the implanted brain tissue. A secondary objective is to investigate the activity of single neurons during specific cognitive tasks.
What is the current status of trial NCT05200455?
This trial is currently completed. It is a NA study. The enrollment target is 34 participants. The study started on 2009-09-18. Estimated completion is 2021-05-18.
What interventions are being tested in trial NCT05200455?
The interventions under investigation include: Microelectrodes (DEVICE).
Who is sponsoring clinical trial NCT05200455?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.